# FDA Inspection 1170196 - Albert Einstein Healthcare Network IRB - May 09, 2022

Source: https://www.keypedia.com/records/fda_inspections/albert-einstein-healthcare-network-irb/a0e514e5-b546-43ae-ab7d-632f5b8e65e7
Source feed: FDA_Inspections

> FDA Inspection 1170196 for Albert Einstein Healthcare Network IRB on May 09, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1170196
- Company Name: Albert Einstein Healthcare Network IRB
- Inspection Date: 2022-05-09
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 889817 - 2014-07-24](https://www.keypedia.com/records/fda_inspections/albert-einstein-healthcare-network-irb/bf4f83d3-aa88-47cd-994e-3d4e5664e834)
- [FDA Inspection 552420 - 2008-12-17](https://www.keypedia.com/records/fda_inspections/albert-einstein-healthcare-network-irb/34c6bcf6-82e8-426c-8d68-8ce9f4f96df8)

Company: https://www.keypedia.com/companies/albert-einstein-healthcare-network-irb/eaa7acca-5da9-4419-bbd7-4008164ef4b6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c